The intravenous injection of CD11b or CD18 monoclonal antibodies in rats at 2-4 hours after transient cerebral ischemia also showed protective effects after 2 days and 7 days of cerebral ischemia [229, 230]. This evidence concerns the gene ITGAM and brain ischemia.